Hexapradol

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by DMacks (talk | contribs) at 04:22, 22 June 2020 (Remove malformatted |molecular_weight= when infobox can autocalculate it, per Wikipedia talk:WikiProject Pharmacology#Molecular weights in drugboxes (via WP:JWB)). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Hexapradol
Clinical data
Other namesα-butyl-β-hydroxy-β-phenylamphetamine
α-pentyl-β-hydroxy-β-phenyl-2-phenethylamine
β-phenyl-2-phenylheptanolamine
ATC code
  • None
Identifiers
  • 2-amino-1,1-diphenyl-1-heptanol
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC19H25NO
Molar mass283.415 g·mol−1
3D model (JSmol)
  • OC(c1ccccc1)(c2ccccc2)C(N)CCCCC
  • InChI=1S/C19H25NO/c1-2-3-6-15-18(20)19(21,16-11-7-4-8-12-16)17-13-9-5-10-14-17/h4-5,7-14,18,21H,2-3,6,15,20H2,1H3
  • Key:ZVRZJTRBWTVKOJ-UHFFFAOYSA-N

Hexapradol (INN) is a psychostimulant drug which was never marketed.[1]

Synthesis

GB 805511 , (1958); CA, 53, 12249

See also

References

  1. ^ Dictionary of Pharmacological Agents Volume 2. CRC Press. p. 1023. ISBN 978-0-412-46630-4. Retrieved 26 April 2012.